{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:58:27Z","timestamp":1769605107513,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1016\/s0006-8993(98)00926-3","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T21:55:17Z","timestamp":1027634117000},"page":"65-75","source":"Crossref","is-referenced-by-count":97,"title":["Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation"],"prefix":"10.1016","volume":"812","author":[{"given":"Gary E","family":"Duncan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy N","family":"Leipzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B","family":"Mailman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery A","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0006-8993(98)00926-3_BIB1","first-page":"95","article-title":"The phenomenology of experimentally induced amphetamine psychosis-preliminary observations","volume":"2","author":"Angrist","year":"1970","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB2","first-page":"226","article-title":"Clozapine and haloperidol modulate N-methyl-d-aspartate- and non-N-methyl-d-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro","volume":"283","author":"Arvanov","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0010-440X(61)80033-3","article-title":"Observations on the psychotomimetic effects of sernyl","volume":"2","author":"Bakker","year":"1961","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB4","first-page":"787","article-title":"Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response","volume":"271","author":"Bakshi","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB5","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1097\/00001756-199512150-00014","article-title":"Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia","volume":"6","author":"Banerjee","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1476-5381.1993.tb13520.x","article-title":"The glycine\/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents","volume":"108","author":"Bristow","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-8993(92)91195-K","article-title":"Regulation of excitatory amino acid release by N-methyl-d-aspartate receptors in rat striatum: in vivo microdialysis studies","volume":"585","author":"Bustos","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01271550","article-title":"Behavioral and neurochemical interactions of the AMPA antagonist GYKI 52466 and the noncompetitive NMDA antagonist dizocilpine in rats","volume":"101","author":"Bubser","year":"1995","journal-title":"J. Neural. Transm. Gen. Sect."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02246146","article-title":"Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonist-induced behaviors","volume":"120","author":"Corbett","year":"1995","journal-title":"Psychopharm."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1213\/00000539-196601000-00007","article-title":"Dissociative anesthesia: further pharmacologic studies and first clinical experience with phencyclidine derivative Cl-581","volume":"45","author":"Corssen","year":"1966","journal-title":"Anesth. Analg."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1192\/bjp.106.444.912","article-title":"The effect of 1-arylcyclohexylamine (sernyl) on twelve normal volunteers","volume":"106","author":"Davies","year":"1960","journal-title":"J. Ment. Sci."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB13","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-198902000-00001","article-title":"A glutamate hypothesis of schizophrenia","volume":"12","author":"Deutsch","year":"1989","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB15","doi-asserted-by":"crossref","unstructured":"G.E. Duncan, High resolution autoradiographic imaging of brain activity patterns with 2-deoxyglucose: regional topographic and cellular analysis, in: F. Gonzalez-Lima, Th. Finkenstadt, H. Scheich (Eds.), Advances in metabolic mapping techniques for brain imaging of behavioral and learning functions, NATO Advanced Science Institute Series, Vol. 68, 1992, pp. 152\u2013173.","DOI":"10.1007\/978-94-011-2712-7_5"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0301-0082(91)90023-T","article-title":"Brain activity patterns: Assessment by high resolution autoradiographic imaging of radiolabeled 2-deoxyglucose and glucose uptake","volume":"37","author":"Duncan","year":"1991","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB17","doi-asserted-by":"crossref","unstructured":"G.E. Duncan, W.E. Stumpf, High resolution autoradiographic imaging of brain activity patterns with radiolabeled 2-deoxyglucose, in: P.M. Conn (Ed.), Methods in Neurosciences, Vol. 3, Academic Press, New York, 1990, pp. 50\u201364.","DOI":"10.1016\/B978-0-12-185255-9.50008-0"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB18","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1523\/JNEUROSCI.13-09-03932.1993","article-title":"Topographic patterns of brain activity in response to swim stress: Assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity","volume":"13","author":"Duncan","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB19","first-page":"1076","article-title":"Functional classification of antidepressants based upon antagonism of swim stress-induced Fos-like immunoreactivity","volume":"277","author":"Duncan","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(97)01390-5","article-title":"Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia","volume":"787","author":"Duncan","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-3223(93)90265-F","article-title":"Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity","volume":"34","author":"Farber","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0920-9964(96)00024-2","article-title":"Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity","volume":"21","author":"Farber","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1993.1153","article-title":"Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-d-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex","volume":"123","author":"Fix","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(84)90404-7","article-title":"The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity","volume":"104","author":"Freeman","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(90)90823-R","article-title":"Non-competitive N-methyl-d-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons","volume":"119","author":"French","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archpsyc.1972.01750200001001","article-title":"d-amphetamine: evaluation of psychotomimetic properties in man","volume":"26","author":"Griffith","year":"1972","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/schbul\/23.3.437","article-title":"Functional and anatomical aspects of prefrontal pathology in schizophrenia","volume":"23","author":"Goldman-Rakic","year":"1997","journal-title":"Schizophr. Bull."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01277027","article-title":"Clozapine improves dizocilpine-induced delayed alternation impairments in rats","volume":"94","author":"Hauber","year":"1993","journal-title":"J. Neural. Transm. Gen. Sect."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/BF00173207","article-title":"The non-NMA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine","volume":"348","author":"Hauber","year":"1993","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01245347","article-title":"Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats","volume":"89","author":"Hoffman","year":"1992","journal-title":"J. Neural Trans."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0006-8993(94)91558-X","article-title":"Effect of phencyclidine on dopamine release in the rat prefrontal cortex, an in vivo microdialysis study","volume":"633","author":"Hondo","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(96)01290-5","article-title":"MK-801-induced neuronal damage in rats","volume":"753","author":"Horvath","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0014-2999(90)90387-L","article-title":"NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus","volume":"187","author":"Imperato","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB34","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01245233","article-title":"In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acid release","volume":"91","author":"Keefe","year":"1993","journal-title":"J. Neural. Transm."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of noncompetitive NMDA antagonist, ketamine, in humans","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","article-title":"Ketamine activates psychosis and alters limbic blood flow in schizophrenia","volume":"6","author":"Lahti","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00216006","article-title":"Provocative tests with psychostimulant drugs in schizophrenia","volume":"91","author":"Lieberman","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB40","first-page":"1209","article-title":"Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation","volume":"274","author":"Liu","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug\u2014sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"Arch. Neurol. Psych."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhortra","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0006-3223(96)00546-X","article-title":"Clozapine blunts N-methyl-d-aspartate antagonist-induced psychosis: a study with ketamine","volume":"42","author":"Malhortra","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF01277672","article-title":"The apparent antipsychotic action of the 5-HT2a receptor antagonist MDL-100907 in a mouse model of schizophrenia is counteracted by ritanserin","volume":"104","author":"Martin","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(91)91431-Y","article-title":"Neuroanatomical characterization of inferior collicular seizure genesis: 2-deoxyglucose and stimulation mapping","volume":"567","author":"McCown","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(95)00970-X","article-title":"Metabolic and functional mapping of the neural network subserving inferior collicular seizure generalization","volume":"701","author":"McCown","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/S0007125000298280","article-title":"Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review","volume":"168","author":"Meltzer","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB49","first-page":"238","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and Serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/schbul\/2.1.19","article-title":"The dopamine hypothesis of schizophrenia: A review","volume":"2","author":"Meltzer","year":"1976","journal-title":"Schizophr. Bull."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB51","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamaterigic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/exnr.1996.0022","article-title":"Haloperidol prevents ketamine and phencyclidine induced hsp70 protein expression but not microglial activation","volume":"137","author":"Nakki","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1192\/bjp.170.2.134","article-title":"Neuropsychological correlates of syndromes in schizophrenia","volume":"170","author":"Norman","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/S0007125000298309","article-title":"Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs review of D2 of 5-HT2 receptor occupancy studies and clinical response","volume":"168","author":"Nyberg","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB55","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1835799","article-title":"NMDA antagonist neurotoxicity: Mechanism and protection","volume":"54","author":"Olney","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB56","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB57","unstructured":"G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, 1997."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB58","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0024-3205(89)90163-X","article-title":"Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo","volume":"45","author":"Rao","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB59","first-page":"1541","article-title":"Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blocade","volume":"277","author":"Schmidt","year":"1996","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0893-133X(96)00187-X","article-title":"Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors","volume":"16","author":"Seeman","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB61","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0006-8993(95)00477-8","article-title":"DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp 70 heat shock gene in the rat cingulate and retrosplenial cortex","volume":"687","author":"Sharp","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB62","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jnr.490330413","article-title":"Haloperidol and rimcazole prevent induction of HSP72 protein and hsp70 mRNA in neurons injured by phencyclidine and MK-801","volume":"33","author":"Sharp","year":"1992","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB63","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.184.4143.1243","article-title":"Drugs, neurotransmitters, and schizophrenia","volume":"184","author":"Snyder","year":"1974","journal-title":"Science"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB64","first-page":"201","article-title":"Electrophysiological effects of selective \u03c3-receptor agonists, antagonists and the selective phencyclidine receptor agonist, MK-801 on midbrain dopamine neurons","volume":"2","author":"Steinfels","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01245040","article-title":"MK-801-induced stereotypy and its antagonism by neuroleptic drugs","volume":"81","author":"Tiedtke","year":"1990","journal-title":"J. Neural. Transm. Gen. Sect."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB66","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1523\/JNEUROSCI.16-01-00373.1996","article-title":"NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine","volume":"16","author":"Verma","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB67","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0893-133X(98)00003-7","article-title":"M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice","volume":"19","author":"Wang","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0006-8993(98)00926-3_BIB68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-8993(93)90839-F","article-title":"MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors","volume":"622","author":"Wedzony","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB69","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0091-3057(93)90217-H","article-title":"The role of dopamine and AMPA\/kainate receptors in the nucleus accumbens in the hypermotility response to MK801","volume":"46","author":"Willins","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0006-8993(98)00926-3_BIB70","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008877-199308000-00017","article-title":"Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system","volume":"4","author":"Wolf","year":"1993","journal-title":"Behav. Pharmacol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899398009263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899398009263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T18:36:34Z","timestamp":1580236594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899398009263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":70,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["S0006899398009263"],"URL":"https:\/\/doi.org\/10.1016\/s0006-8993(98)00926-3","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}